Trademarkia Logo

United Kingdom

£
Trademark Search
Senzer

View On IPO.GOV.UK

Registered

on 3 Mar 2015

Last Applicant/ Owned by

Senzer Limited

Senzer Limited, 2 Angel Square

London, , EC1V1NY

Serial Number

UK00913791124 filed on 3rd Mar 2015

Registration Number

UK00913791124 registered on
28th Jun 2017

Correspondent Information

Boult Wade Tennant LLP

Salisbury Square House, 8 Salisbury Square

London,

EC4Y 8AP

Senzer

pharmaceutical preparations for the treatment of pain, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, drug addiction, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, mental illness, and other intestinal, neurological and cardiovascular disorders; substances adapted for medical use for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, drug addiction, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, other intestinal, neurological and cardiovascular disorders; vaccines for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, drug addiction, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, mental illness, and intestinal and cardiovascular disorders; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, drug addiction, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, mental illness, and other intestinal, neurological and cardiovascular disorders; drug delivery agents in the form of powders, capsules, inhalers, that facilitate the delivery of pharmaceutical preparations; none of the aforesaid being for or in relation to preparations for the treatment of liver diseases.

Class [10]
Medical Instrument Products

Inhalers; filters for inhalers; inhalers for medical use; inhalers for therapeutic use; drug delivery systems; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; microneedle arrays for delivering medications; hypodermic syringes for injections for medical purposes; all of the aforesaid for use in delivering pharmaceutical preparations for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, mental illness, and intestinal, neurological and cardiovascular disorders; none of the aforesaid being for or in relation to preparations for the treatment of liver diseases.

Mark Details

Serial Number

UK00913791124

Mark Type

Word

Kind of mark

Individual